ADINI DERMATOLOGY LIMITED
Opportunity 81/100 (exceptional), bankability 75/100. Same-surname younger director in place — likely family handover, not open to sale. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (73/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Strong composite across quality, acquirability, and risk. High-priority target — progress to serious diligence.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredKey financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-05-31 | 2024-05-31 |
|---|---|---|
| Total assets | £1.15M | £1.02M |
| Current assets | £1.17M | £1.01M |
| Cash | £952.7k | £815.5k |
| Debtors | £151.0k | £22.3k |
| Net assets | £1.15M | £1.01M |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
2 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
- • 1 accounts
Corporate timeline (21 events)Click to expand
- 2026-02-03📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-10-04📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-02-06📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-05-17📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2023-03-20📄capital-allotment-sharescapital · SH01
- 2023-03-20📄capital-allotment-sharescapital · SH01
- 2023-03-20📄appoint-person-director-company-with-name-dateofficers · AP01
- 2023-03-20📄appoint-person-director-company-with-name-dateofficers · AP01
- 2023-03-20📄appoint-person-director-company-with-name-dateofficers · AP01
- 2023-03-20📄change-person-director-company-with-change-dateofficers · CH01
- 2023-03-20📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2023-02-24📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-11-12➕BHAT, Aditi appointeddirector
- 2022-06-03➕BHAT, Anirudh appointeddirector
- 2022-06-03➕BHAT, Roopashree Jaideep, Dr appointeddirector
- 2022-02-28📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-02-23📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-02-25📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-02-25📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2010-05-11🏢Company incorporatedAs ADINI DERMATOLOGY LIMITED
- 2010-05-11➕BHAT, Jaideep, Dr appointeddirector
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- -4 active directors: Broader management team in place — suggests transferable governance.
- +Long-tenure founder: Senior director has been in place 16 years — deep operational knowledge concentrated in one person.
- +Senior director age: Director aged approximately 59 — approaching natural succession window.
- +Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.
Succession & seller-readiness
No meaningful acquirability indicators from public data.
- primaryFamily succession underway: Not a takeover target — BHAT, Aditi (same surname) appointed 2022-11-12. Pattern consistent with intra-family handover.
- secondaryFounder aged 58+: Senior director is approximately 59. Early succession window.
- secondary12+ year tenure: Director in role 16 years.
- secondaryStable-but-static management: Company is 16 years old and no new directors in the last 3 years — succession not yet being planned internally.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Jaideep Bhat Individual · British · DOB 06/1967 · age 59 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 11/05/2017 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · BB postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A G STOUT OPTOMETRIC SERVICES LIMITED→ 05911276 · est 2006 · no financials extracted | — | — | — | — | 19y | — | — |
| ACTIVATION HEALTH LTD→ 15695350 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ACTIVE NEIGHBOURHOODS CIC→ 17045132 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| ACUMINDS CIC→ 16941543 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| ADAM'S ACTIVITY ARK CIC→ 13188659 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| ADAMS HOMECARE LTD→ 14921780 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ADESSO OCCUPATIONAL HEALTH & WELLBEING LTD→ 14964032 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ADORA - HEALTH & WELLBEING LTD→ 13629172 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| ADORE HOME CARE LTD→ 07640881 · est 2011 · no financials extracted | — | — | — | — | 14y | — | — |
| ADVANCE MEDICA LTD→ 08471830 · est 2013 · no financials extracted | — | — | — | — | 13y | — | — |
| ADVANCE OCCUPATIONAL THERAPY LIMITED→ 10846233 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| ADVANCE SOCIAL CARE LIMITED→ 09526102 · est 2015 · no financials extracted | — | — | — | — | 11y | — | — |
6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (4 active · 0 resigned)
Click a director name to see their full track record across all companies.